BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 33677093)

  • 1. The cardiac translational landscape reveals that micropeptides are new players involved in cardiomyocyte hypertrophy.
    Yan Y; Tang R; Li B; Cheng L; Ye S; Yang T; Han YC; Liu C; Dong Y; Qu LH; Lui KO; Yang JH; Huang ZP
    Mol Ther; 2021 Jul; 29(7):2253-2267. PubMed ID: 33677093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The translational landscape of human vascular smooth muscle cells identifies novel short open reading frame-encoded peptide regulators for phenotype alteration.
    Li K; Li B; Zhang D; Du T; Zhou H; Dai G; Yan Y; Gao N; Zhuang X; Liao X; Liu C; Dong Y; Chen D; Qu LH; Ou J; Yang JH; Huang ZP
    Cardiovasc Res; 2023 Jul; 119(8):1763-1779. PubMed ID: 36943764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy.
    Liu L; An X; Li Z; Song Y; Li L; Zuo S; Liu N; Yang G; Wang H; Cheng X; Zhang Y; Yang X; Wang J
    Cardiovasc Res; 2016 Jul; 111(1):56-65. PubMed ID: 27084844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring Cell-Type-Specific Gene Expression Using Ribosome Profiling In Vivo During Cardiac Hemodynamic Stress.
    Doroudgar S; Hofmann C; Boileau E; Malone B; Riechert E; Gorska AA; Jakobi T; Sandmann C; Jürgensen L; Kmietczyk V; Malovrh E; Burghaus J; Rettel M; Stein F; Younesi F; Friedrich UA; Mauz V; Backs J; Kramer G; Katus HA; Dieterich C; Völkers M
    Circ Res; 2019 Aug; 125(4):431-448. PubMed ID: 31284834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes.
    Li H; Shi S; Sun YH; Zhao YJ; Li QF; Li HZ; Wang R; Xu CQ
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):312-8. PubMed ID: 18986329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA cytoskeleton regulator RNA (CYTOR) modulates pathological cardiac hypertrophy through miR-155-mediated IKKi signaling.
    Yuan Y; Wang J; Chen Q; Wu Q; Deng W; Zhou H; Shen D
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1421-1427. PubMed ID: 30794866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Noncoding RNA
    Yu J; Yang Y; Xu Z; Lan C; Chen C; Li C; Chen Z; Yu C; Xia X; Liao Q; Jose PA; Zeng C; Wu G
    Circ Heart Fail; 2020 Jan; 13(1):e006525. PubMed ID: 31957467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial natriuretic peptide inhibits cardiomyocyte hypertrophy through mitogen-activated protein kinase phosphatase-1.
    Hayashi D; Kudoh S; Shiojima I; Zou Y; Harada K; Shimoyama M; Imai Y; Monzen K; Yamazaki T; Yazaki Y; Nagai R; Komuro I
    Biochem Biophys Res Commun; 2004 Sep; 322(1):310-9. PubMed ID: 15313208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microtubules orchestrate local translation to enable cardiac growth.
    Scarborough EA; Uchida K; Vogel M; Erlitzki N; Iyer M; Phyo SA; Bogush A; Kehat I; Prosser BL
    Nat Commun; 2021 Mar; 12(1):1547. PubMed ID: 33707436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eicosapentaenoic acid prevents endothelin-1-induced cardiomyocyte hypertrophy in vitro through the suppression of TGF-beta 1 and phosphorylated JNK.
    Shimojo N; Jesmin S; Zaedi S; Maeda S; Soma M; Aonuma K; Yamaguchi I; Miyauchi T
    Am J Physiol Heart Circ Physiol; 2006 Aug; 291(2):H835-45. PubMed ID: 16501010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long non-coding RNA NRON promotes the development of cardiac hypertrophy in the murine heart.
    Hoepfner J; Leonardy J; Lu D; Schmidt K; Hunkler HJ; Biß S; Foinquinos A; Xiao K; Regalla K; Ramanujam D; Engelhardt S; Bär C; Thum T
    Mol Ther; 2022 Mar; 30(3):1265-1274. PubMed ID: 34856383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors.
    Ganesan J; Ramanujam D; Sassi Y; Ahles A; Jentzsch C; Werfel S; Leierseder S; Loyer X; Giacca M; Zentilin L; Thum T; Laggerbauer B; Engelhardt S
    Circulation; 2013 May; 127(21):2097-106. PubMed ID: 23625957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translation of Small Open Reading Frames: Roles in Regulation and Evolutionary Innovation.
    Ruiz-Orera J; Albà MM
    Trends Genet; 2019 Mar; 35(3):186-198. PubMed ID: 30606460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The angiotensin II type 2 receptor causes constitutive growth of cardiomyocytes and does not antagonize angiotensin II type 1 receptor-mediated hypertrophy.
    D'Amore A; Black MJ; Thomas WG
    Hypertension; 2005 Dec; 46(6):1347-54. PubMed ID: 16286564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of heterotrimeric G protein and calcium in cardiomyocyte hypertrophy induced by IGF-1.
    Carrasco L; Cea P; Rocco P; Peña-Oyarzún D; Rivera-Mejias P; Sotomayor-Flores C; Quiroga C; Criollo A; Ibarra C; Chiong M; Lavandero S
    J Cell Biochem; 2014 Apr; 115(4):712-20. PubMed ID: 24243530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Miro1 as a novel regulator of hypertrophy in neonatal rat cardiomyocytes.
    Conejeros C; Parra V; Sanchez G; Pedrozo Z; Olmedo I
    J Mol Cell Cardiol; 2020 Apr; 141():65-69. PubMed ID: 32234389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global analysis of ribosome-associated noncoding RNAs unveils new modes of translational regulation.
    Bazin J; Baerenfaller K; Gosai SJ; Gregory BD; Crespi M; Bailey-Serres J
    Proc Natl Acad Sci U S A; 2017 Nov; 114(46):E10018-E10027. PubMed ID: 29087317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accurate detection of short and long active ORFs using Ribo-seq data.
    Choudhary S; Li W; D Smith A
    Bioinformatics; 2020 Apr; 36(7):2053-2059. PubMed ID: 31750902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the cardiomyocyte transcriptome vs translatome by endothelin-1 and insulin: translational regulation of 5' terminal oligopyrimidine tract (TOP) mRNAs by insulin.
    Markou T; Marshall AK; Cullingford TE; Tham el L; Sugden PH; Clerk A
    BMC Genomics; 2010 May; 11():343. PubMed ID: 20509958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
    Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.